Stay updated on Inhaled ZYESAMI Clinical Trial
Sign up to get notified when there's something new on the Inhaled ZYESAMI Clinical Trial page.

Latest updates to the Inhaled ZYESAMI Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a small update to the page metadata.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing v3.6.4, representing a metadata version update rather than a change to study content.SummaryDifference0.0%

- Check51 days agoChange DetectedA new Revision: v3.6.4 appears, replacing Revision: v3.6.3, indicating an update to the page’s version rather than changes to the study content. This reflects a backend or template update rather than substantive changes to the study details.SummaryDifference0.0%

- Check66 days agoChange DetectedThe sponsor name APR Applied Pharma Research s.a. and the Pathogenesis of COVID-19 from a cell biologic perspective section have been removed. The Helpful Links Provided by section is also deleted, reducing background context and source attribution on the study details page.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a minor update to the ClinicalTrials.gov record. This does not modify the study details, eligibility criteria, or results.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page's revision tag was updated to v3.6.2, replacing the previous v3.6.0. This reflects a newer revision of the page's documentation rather than a change to its substantive content.SummaryDifference0.0%

Stay in the know with updates to Inhaled ZYESAMI Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled ZYESAMI Clinical Trial page.